Month: May 2026

2026.06.03
Genomtec Secures Over EUR 9 Million to Advance Commercialization Strategy and AI-Powered Diagnostics Development

2026.05.19
Launch of the public offering of Genomtec shares to raise funds for the finalization of the M&A process and the commercialization of Genomtec ID and OncoSNAAT® technologies

2026.03.19
Genomtec plans to issue shares. The proceeds will be used to support the M&A process and commercialize projects. The company has concluded an investment agreement with a key shareholder.

2026.02.12
Genomtec lines up technology trials with potential Asian partners during M&A efforts

2025.07.31
Genomtec's Supervisory Board appointed Leroy Huntley to the Company's Management Board

Archive

2026.05.19

Launch of the public offering of Genomtec shares to raise funds for the finalization of the M&A process and the commercialization of Genomtec ID and OncoSNAAT® technologies

Genontec S.A. announced the launch of a public offering of shares by its principal shareholder, 5HT Family Foundation, through an accelerated ...
Read

Archive